Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Graft vs Host Disease × Brentuximab Vedotin × 90 days × Clear all

Sponsor

Conditions

Hodgkin Disease 5 Mycosis Fungoides 2 Lymphoma 2 Squamous Cell Carcinoma of Head and Neck 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Neoplasms 1 Melanoma 1 Lymphomatoid Papulosis 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Primary Cutaneous Anaplastic Large Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1 Hematologic Diseases 1 Carcinoma, Non-Small-Cell Lung 1 Ann Arbor Stage IIB Hodgkin Lymphoma 1

Interventions

ruxolitinib 4 Cyclophosphamide 4 Mycophenolic Acid 3 fludarabine 2 Tacrolimus 2 Methotrexate 2 Busulfan 2 blinatumomab 1 belumosudil 1 axatilimab 1 Whole-Body Irradiation 1 Vorinostat 1 Thiotepa 1 Sirolimus 1 Panobinostat 1 Low-Level Light Therapy 1 Interferon-gamma 1 Cyclosporine 1 Clofarabine 1 Blood Specimen Collection 1 Biopsy 1 Adrenal Cortex Hormones 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡